11:05 AM EDT, 09/29/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts opened the week modestly higher late Monday morning, increasing 0.22% to 1,548.79 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Genfit ( GNFT ) and internet browser company Opera (OPRA), which rose 5.9% and 5.7%, respectively. They were followed by semiconductor company Sequans Communications ( SQNS ) and biopharmaceutical company Grifols ( GRFS ) , which were up 4.6% and 1.7%, respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis ( CLLS ) and medical device maker EDAP TMS ( EDAP ) , which shed 22% and 2.4%, respectively. They were followed by petroleum refiner Equinor ( EQNR ) and oil and gas company TotalEnergies (TTE), which fell 2.3% and 1.6%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Bicycle Therapeutics ( BCYC ) , which climbed 8.8% and 3.4%, respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which advanced 3.2% and 2%, respectively.

The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and oil and gas company BP (BP), which dropped 2.8% and 2.1%, respectively. They were followed by tobacco company British American Tobacco ( BTI ) and oil and gas company Shell (SHEL), which were down 1.2% and 1.1%, respectively.